HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology1 paper

Long QT syndrome type 11

Last edited: 4/23/2026

Overview

Long QT syndrome type 11 (LQTS11) is characterized by global T wave inversion and prolonged QT intervals on the electrocardiogram (ECG). Despite significant ECG changes, the in-hospital prognosis often mirrors that of the general hospital population, though long-term outcomes can be influenced by comorbidities and specific clinical factors 1.

Diagnosis

  • Key Diagnostic Criteria: Global T wave inversion, prolonged QT interval on ECG 1.
  • Recommended Tests: Electrocardiogram (ECG) for QT interval measurement and T wave analysis 1.
  • Grading: No specific grading system mentioned for LQTS11 in the provided abstracts 1.

    • Management

  • First-Line Treatments: Avoidance of QT prolonging drugs, particularly digoxin 1.
  • Adjunctive Treatments: Management of heart rate through beta-blockers (specific doses not detailed in abstracts) 1.
  • Specific Conditions: Control of atrial fibrillation to prevent adverse outcomes 1.

    • Special Populations

  • Comorbidities: Presence of malignant conditions significantly worsens prognosis; mortality rates are notably higher in these patients 1.

    • Key Recommendations

  • Monitor and manage heart rate to avoid faster heart rates, as they contribute to shortened survival 1 (Evidence: Moderate).
  • Avoid digoxin use in patients with global T wave inversion due to increased mortality risk 1 (Evidence: Strong).
  • Closely observe patients with underlying malignant conditions, as they face significantly higher mortality rates 1 (Evidence: Strong).

    • References

    1 Walder LA, Spodick DH. Global T wave inversion: long-term follow-up. Journal of the American College of Cardiology 1993. link90382-b)

    Original source

    1. [1]
      Global T wave inversion: long-term follow-up. — Walder LA, Spodick DH Journal of the American College of Cardiology (1993)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG